Michelle Andrews - KFF Health News
-
Many proposals have been floated about how to address the nation’s primary care problem. They range from training slots to medical school debt forgiveness but often sidestep comprehensive payment reform.
-
The point isn’t that Donald Trump managed drug shortages badly as president or that Joe Biden is handling them badly now, experts said. Many factors contribute to the problem.
-
Before COVID, hepatitis C held the distinction of claiming more American lives each year than any other infectious disease — that’s despite the marketing of several relatively affordable, highly effective treatments.
-
The Vermont senator sees beefing up the primary care workforce as a critical step in expanding Americans’ access to health care.
-
Consumers should know that medical identity theft can happen, whether from a large-scale breach or theft of an individual's data. The result could be thousands of dollars in medical bills.
-
The Food and Drug Administration’s approval is viewed as groundbreaking, but many details still must be figured out.
-
Some medical professionals are concerned the decision could have implications for the diversity of medical students, the practice of medicine, and patient care.
-
The “front door” to the health system is changing, under pressure from increased demand, consolidation, and changing patient expectations.
-
Sen. Bernie Sanders’ broad statement on U.S. drug prices doesn’t paint the full picture. Studies we examined generally found that U.S. prices were 2 to 4 times those in other countries, not 10.
-
Advocates and lawmakers worry high lawyer fees could shortchange those injured from toxic exposure at the military base after the Camp Lejeune Justice Act became law.